Bionano Genomics Inc (BNGO) Stock Price, Quote & News

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858 888 7600

Website: bionano.com

Address:

9540 Towne Centre Drive, Suite 100, San Diego, United States

Twan408 Sep. 16 at 11:49 PM

$BNGO I remember years ago riding this from 50c to $15 (when this peaked at $9,000 in today’s value). WTF happened here? Not trying to brag either. I might as well have stayed invested in BNGO because I nearly lost it all on another stupid risky investment that I held too long.. any long holders here? Any one from 2021?

2 · Reply

YouVSYou Sep. 16 at 11:41 PM

$BNGO in the gap over 1.86

0 · Reply

Tsupitito Sep. 16 at 11:11 PM

$BNGO I'll probably enter when the market cap reaches 2m or lower. Maybe this will go down to under a dollar again and reverse split it then reaches a dollar again.. that's when I jump in. Patience is key here everyone.

0 · Reply

rcarigl23 Sep. 16 at 10:21 PM

$BNGO

0 · Reply

mitrevsky Sep. 16 at 9:05 PM

$BNGO the worst investment of my life, what was I thinking?

0 · Reply

09xx Sep. 16 at 8:46 PM

$BNGO retarded CEO burned 1G for shit acquisitions

0 · Reply

maxvishphoto Sep. 16 at 8:29 PM

$BNGO price target?

1 · Reply

MisterNessuno Sep. 16 at 8:03 PM

$BNGO tomorrow new emissione at 1$

0 · Reply

BuIl2030 Sep. 16 at 6:59 PM

$BNGO why are they down so much

1 · Reply

Snow120 Sep. 16 at 6:59 PM

$BNGO where is SEC?????????This company is scam. how many time r/s and offering???????

2 · Reply

Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge

Sep 16, 2025, 7:00 AM EDT - 15 hours ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 15, 2025, 7:00 AM EDT - 1 day ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Aug 25, 2025, 8:00 AM EDT - 22 days ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 15, 2025, 4:37 AM EDT - 4 weeks ago

Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:01 PM EDT - 4 weeks ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 7, 2025, 8:00 AM EDT - 5 weeks ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 6, 2025, 8:00 AM EDT - 5 weeks ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 6 weeks ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

May 19, 2025, 8:00 AM EDT - 4 months ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 14, 2025, 7:46 PM EDT - 4 months ago

Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 4 months ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 13, 2025, 8:00 AM EDT - 4 months ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 7, 2025, 4:01 PM EDT - 4 months ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 2, 2025, 9:30 AM EDT - 4 months ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Apr 23, 2025, 8:00 AM EDT - 5 months ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 8, 2025, 8:00 AM EDT - 5 months ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Mar 31, 2025, 8:11 PM EDT - 6 months ago

Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:01 PM EDT - 6 months ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 24, 2025, 8:00 AM EDT - 6 months ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 18, 2025, 8:00 AM EDT - 6 months ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 14, 2025, 8:00 AM EDT - 6 months ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 13, 2025, 9:00 AM EDT - 6 months ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Jan 22, 2025, 4:05 PM EST - 8 months ago

Bionano Announces Effective Date of Reverse Stock Split

Jan 6, 2025, 4:30 PM EST - 9 months ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 9 months ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Dec 31, 2024, 3:26 PM EST - 9 months ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 9 months ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Nov 13, 2024, 7:11 PM EST - 10 months ago

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 10 months ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 4, 2024, 4:14 AM EST - 11 months ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Oct 31, 2024, 4:30 PM EDT - 11 months ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 8:10 AM EDT - 11 months ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Aug 13, 2024, 7:23 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Aug 7, 2024, 7:11 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 8, 2024, 5:25 PM EDT - 1 year ago

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 5, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

Jun 20, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA CTKB DHR LAB MASS OMIC QGEN

May 8, 2024, 7:12 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Apr 4, 2024, 1:44 PM EDT - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 3, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

Mar 7, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ System

Twan408 Sep. 16 at 11:49 PM

2 · Reply

YouVSYou Sep. 16 at 11:41 PM

$BNGO in the gap over 1.86

0 · Reply

Tsupitito Sep. 16 at 11:11 PM

0 · Reply

rcarigl23 Sep. 16 at 10:21 PM

$BNGO

0 · Reply

mitrevsky Sep. 16 at 9:05 PM

$BNGO the worst investment of my life, what was I thinking?

0 · Reply

09xx Sep. 16 at 8:46 PM

$BNGO retarded CEO burned 1G for shit acquisitions

0 · Reply

maxvishphoto Sep. 16 at 8:29 PM

$BNGO price target?

1 · Reply

MisterNessuno Sep. 16 at 8:03 PM

$BNGO tomorrow new emissione at 1$

0 · Reply

BuIl2030 Sep. 16 at 6:59 PM

$BNGO why are they down so much

1 · Reply

Snow120 Sep. 16 at 6:59 PM

$BNGO where is SEC?????????This company is scam. how many time r/s and offering???????

2 · Reply

Saif101 Sep. 16 at 6:49 PM

$BNGO next RS coming !!

0 · Reply

CristoferAtlantis Sep. 16 at 6:45 PM

$BNGO Anyone here remember Dayo the African Youtuber who put out 700 well researched videos about BNGO and Erik never acknowledged his efforts? It looks to me that Erik was afraid he’d be found out to ve the fraud he is.

1 · Reply

KuruHabesha Sep. 16 at 6:44 PM

$BNGO In with a starter. When some panic sell, others loads up. 🚀🐂

2 · Reply

Back_to_Map Sep. 16 at 6:13 PM

$BNGO damn, i remember it was $15 stock in past…

0 · Reply

tricksupmysleeve Sep. 16 at 6:11 PM

$WHLR $OPI $BNGO

0 · Reply

Bizingo Sep. 16 at 5:56 PM

$BNGO Eric is one shady man. Was able to scam and pump this up to 5 bucks and then dump with the offerings. Unbelievable the SEC lets this slide.

1 · Reply

makeusmoney Sep. 16 at 5:16 PM

$BNGO take a look at NAKA ticket. The company’s market cap is now well beneath the value of its 5,765 BTC, marking a discount to its bitcoin per share. It is low floats.

0 · Reply

Xochi_Research_Group Sep. 16 at 4:58 PM

$BNGO I tried and failed I didn't believe this idiot would do an offering again but he wants to go on a nice vacation I guess

1 · Reply

Xochi_Research_Group Sep. 16 at 4:58 PM

$BNGO offering just in time for winter vacation

0 · Reply

YouVSYou Sep. 16 at 4:58 PM

$BCDA $BNGO Sellers getting exhausted

0 · Reply

JumpStarting Sep. 16 at 4:46 PM

$BNGO Garbage! It went up to $5 and now $1.64 , what a mess! My shares cost me 145 and 196 dollars each on different accounts. How long do I wait for this crap to go back to where it was? What a mess! Fire the stupid CEO.

1 · Reply

Keepitmoving Sep. 16 at 4:40 PM

$BNGO Is this person really that dumb?!? Literally the reason why scumbag scammers like Holmlin keep going. 🤦‍♂️

0 · Reply

Market Cap	18.16M
Revenue (ttm)	30.78M
Net Income (ttm)	-112.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-363.94%
Debt to Equity Ratio	0.00

Volume	12,250,900
Avg Vol	173,028
Day's Range	N/A - N/A
Shares Out	4.68M
Stochastic %K	17%
Beta	2.25
Analysts	Strong Sell
Price Target	$9.50